HRMY
Harmony Biosciences Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$34.78
−6.05%Forward multiples
Based on analyst estimates
- P/E forward
- 8.80x
- P/E 2026E
- 8.69x
- P/E 2027E
- 7.66x
- P/E 2028E
- 6.90x
- P/S forward
- 1.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- 11.11x
- PEG TTM
- 0.41x
- Price / book
- 2.03x
- Price / sales
- 2.11x
- Price / cash flow
- 5.70x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 1.57x
- EV / EBITDA
- 5.47x
- EV / EBIT
- 6.55x
- Market cap
- $2.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026